These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11179604)

  • 21. Central administration of the neurotensin receptor antagonist, SR48692, modulates diurnal and stress-related hypothalamic-pituitary-adrenal activity.
    Rowe WB; Nicot A; Sharma S; Gully D; Walker CD; Rostène WH; Meaney MJ; Quirion R
    Neuroendocrinology; 1997 Aug; 66(2):75-85. PubMed ID: 9263204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice.
    Maoret JJ; Anini Y; Rouyer-Fessard C; Gully D; Laburthe M
    Int J Cancer; 1999 Jan; 80(3):448-54. PubMed ID: 9935189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of intrastriatal neurotensin(1-13) and neurotensin(8-13) on striatal dopamine and pallidal GABA release. A dual-probe microdialysis study in the awake rat.
    Ferraro L; O'Connor WT; Antonelli T; Fuxe K; Tanganelli S
    Eur J Neurosci; 1997 Sep; 9(9):1838-46. PubMed ID: 9383206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurotensin enhances endogenous extracellular glutamate levels in primary cultures of rat cortical neurons: involvement of neurotensin receptor in NMDA induced excitotoxicity.
    Antonelli T; Ferraro L; Fuxe K; Finetti S; Fournier J; Tanganelli S; De Mattei M; Tomasini MC
    Cereb Cortex; 2004 Apr; 14(4):466-73. PubMed ID: 15028650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radionuclide imaging of small-cell lung cancer (SCLC) using 99mTc-labeled neurotensin peptide 8-13.
    Zhang K; An R; Gao Z; Zhang Y; Aruva MR
    Nucl Med Biol; 2006 May; 33(4):505-12. PubMed ID: 16720242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
    Mahmoud S; Staley J; Taylor J; Bogden A; Moreau JP; Coy D; Avis I; Cuttitta F; Mulshine JL; Moody TW
    Cancer Res; 1991 Apr; 51(7):1798-802. PubMed ID: 1848479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
    Wang WL; Healy ME; Sattler M; Verma S; Lin J; Maulik G; Stiles CD; Griffin JD; Johnson BE; Salgia R
    Oncogene; 2000 Jul; 19(31):3521-8. PubMed ID: 10918610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corticotropin-releasing factor receptors in human small cell lung carcinoma cells: radioligand binding, second messenger, and northern blot analysis data.
    Dieterich KD; Grigoriadis DE; De Souza EB
    Endocrinology; 1994 Oct; 135(4):1551-8. PubMed ID: 7925116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotensin may function as a regulatory peptide in small cell lung cancer.
    Davis TP; Crowell S; McInturff B; Louis R; Gillespie T
    Peptides; 1991; 12(1):17-23. PubMed ID: 1646999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide hormones and lung cancer.
    Moody TW
    Panminerva Med; 2006 Mar; 48(1):19-26. PubMed ID: 16633328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SR142948A is a potent antagonist of the cardiovascular effects of neurotensin.
    Schaeffer P; Laplace MC; Bernat A; Prabonnaud V; Gully D; Lespy L; Herbert JM
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):545-50. PubMed ID: 9554803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurotensin inhibits background K+ channels and facilitates glutamatergic transmission in rat spinal cord dorsal horn.
    Kadiri N; Rodeau JL; Schlichter R; Hugel S
    Eur J Neurosci; 2011 Oct; 34(8):1230-40. PubMed ID: 21936876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct functional characteristics of levocabastine sensitive rat neurotensin NT2 receptor expressed in Chinese hamster ovary cells.
    Yamada M; Yamada M; Lombet A; Forgez P; Rostène W
    Life Sci; 1998; 62(23):PL 375-80. PubMed ID: 9627096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations.
    Seethalakshmi L; Mitra SP; Dobner PR; Menon M; Carraway RE
    Prostate; 1997 May; 31(3):183-92. PubMed ID: 9167771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of neurotensin receptor 1 selectively sensitizes prostate cancer to ionizing radiation.
    Valerie NC; Casarez EV; Dasilva JO; Dunlap-Brown ME; Parsons SJ; Amorino GP; Dziegielewski J
    Cancer Res; 2011 Nov; 71(21):6817-26. PubMed ID: 21903767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the neurotensin receptor antagonist SR48692 on rat blood pressure modulation by neurotensin.
    Gully D; Lespy L; Canton M; Rostène W; Kitabgi P; Le Fur G; Maffrand JP
    Life Sci; 1996; 58(8):665-74. PubMed ID: 8594316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurotensin receptor 1 is a new therapeutic target for human undifferentiated pleomorphic sarcoma growth.
    Tokumoto H; Setoguchi T; Saitoh Y; Sasaki H; Nagano S; Maeda S; Tanimoto A; Taniguchi N
    Mol Carcinog; 2019 Dec; 58(12):2230-2240. PubMed ID: 31478563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.
    Moody TW; Zia F; Draoui M; Brenneman DE; Fridkin M; Davidson A; Gozes I
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4345-9. PubMed ID: 8389448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotensin binds with high affinity to small cell lung cancer cells.
    Allen AE; Carney DN; Moody TW
    Peptides; 1988; 9 Suppl 1():57-61. PubMed ID: 2856809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotensin receptor-mediated inhibition of pancreatic cancer cell growth by the neurotensin antagonist SR 48692.
    Herzig MC; Chapman WG; Sheridan A; Rake JB; Woynarowski JM
    Anticancer Res; 1999; 19(1A):213-9. PubMed ID: 10226545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.